Table 2.
Recurrent copy number gains detected by a-CGH in SI-NETs
|
Case no. |
P / |
|
|
|
|
|
|---|---|---|---|---|---|---|
| / M | Chr 4 | Chr 5 | Chr 7 | Chr 14 | Chr 20 | |
| 1 |
M |
(4)pter-15.32 |
(5)pter-15.33; q23.3-ter |
- |
(14q11.1-21.3); q32.12-ter |
20 |
| 3 |
P |
- |
- |
- |
- |
- |
| 4 |
P |
(4)pter-15.2; p14-qter |
(5)pter-15.1; p13.3-qter |
- |
- |
(20)pter-q13.33 |
| 5 |
M |
- |
- |
- |
- |
- |
| 6 |
M |
- |
- |
- |
- |
- |
| 7 |
P |
4 |
5 |
- |
14 |
- |
| 8 |
P |
- |
- |
- |
- |
- |
| 9 |
M |
(4) |
- |
- |
- |
20q12-ter |
| 10 |
P |
- |
- |
- |
- |
- |
| 11 |
P |
- |
- |
- |
- |
- |
| 12 |
P |
- |
- |
- |
- |
- |
| 13 |
P |
- |
- |
- |
- |
- |
| 14 |
P |
(4)pter-16.1; p14-q12 |
(5)pter-14.3; q35.1-ter |
- |
- |
(20)pter-13; q11.21-ter |
| 15 |
P |
- |
- |
- |
- |
20q13.32; qter |
| 16 |
P |
- |
- |
- |
- |
20q11.1-11.21; q13.33 |
| 17 |
P |
- |
- |
- |
- |
- |
| 18 |
P |
- |
- |
- |
- |
- |
| 20 |
P |
- |
- |
- |
14q11.2 |
- |
| 21 |
M |
- |
- |
7q22.3-ter |
- |
- |
| 23 |
M |
- |
- |
- |
(14q11.2) |
- |
| 24 |
M |
- |
- |
- |
- |
20 |
| 25 |
P |
(4)p16.3-12; q22.1-ter |
(5)pter-q35.2 |
- |
(14) q11.1-32.2 |
- |
| 26 |
P |
- |
- |
- |
- |
(20)pter-11.21; q11.23-13.33 |
| 27 |
P |
- |
- |
(7)pter-22.3; p15.3-q35; q35-ter |
(14) q11.2; q23.3-ter |
(20)pter-q13.2; q13.31-ter |
| 27 |
M |
- |
- |
- |
(14q11.2) |
- |
| 28 |
M |
4pter-16.1 |
5pter; q35.2-35.3 |
7p22.3; p22.2-22.1; q22.1; qter |
14q11.2; q32.2-ter |
20p12.1; q13.31-13.32; q13.33-ter |
| 29 |
P |
- |
- |
- |
- |
- |
| 30 |
M |
- |
- |
- |
- |
- |
| 31 |
P |
- |
- |
- |
- |
- |
| 32 | M | (4)q26-35.2 | (5)pter-15.1; q11.1-13.1; q13.2-ter | (7)pter-22.2; p22.1-11.2; q11.23-ter | (14q11.1-32.31) q11.1 | 20pter-11.21; q11.23-ter |
P = primary tumor; M = metastasis; chr= chromosome; Alterations written within parenthesis represent borderline alterations at the threshold.